Stroke, Vol 21, 726-730, Copyright © 1990 by American Heart Association
CL Franke, J de Jonge, JC van Swieten, AA Op de Coul and J van Gijn
We retrospectively studied 79 patients from three centers who suffered an
intracerebral hemorrhage during treatment with anticoagulants and compared
them with 84 patients from one center who suffered a spontaneous
intracerebral hemorrhage without anticoagulant treatment. Mortality after
30 days was slightly higher in patients with anticoagulant treatment (67%)
than in those without (55%), and the proportion of patients who attained
moderate or complete recovery was slightly smaller in the treated group
(22% and 36%, respectively); neither difference was statistically
significant. Volume of the supratentorial hematoma was measured from
computed tomograms in 70% of the patients in both groups and was
significantly greater in the 55 patients treated with anticoagulants than
in the 59 patients not so treated. Volume was not related to the degree of
anticoagulation. Based on the total number of patients treated with
anticoagulants in the Heerlen region, we conclude that for patients older
than 50 years of age the risk of intracerebral hemorrhage during
anticoagulant treatment is increased approximately eightfold but is
unrelated to the degree of anticoagulation. Our results suggest that
intracerebral hemorrhage is more frequent and more extensive in patients
treated with anticoagulants but that once it has occurred in such patients
intracerebral hemorrhage is not significantly more serious than in
untreated patients.
ARTICLES
Intracerebral hematomas during anticoagulant treatment
Department of Neurology, De Wever Ziekenhuis, Heerlen, The Netherlands.
This article has been cited by other articles:
 |
|
 |
|
  C. Foerch, K. Arai, G. Jin, K.-P. Park, S. Pallast, K. van Leyen, and E. H. Lo Experimental Model of Warfarin-Associated Intracerebral Hemorrhage Stroke, December 1, 2008; 39(12): 3397 - 3404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y. Zubkov, J. N. Mandrekar, D. O. Claassen, E. M. Manno, E. F. M. Wijdicks, and A. A. Rabinstein Predictors of Outcome in Warfarin-Related Intracerebral Hemorrhage Arch Neurol, October 1, 2008; 65(10): 1320 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Flaherty, H. Tao, M. Haverbusch, P. Sekar, D. Kleindorfer, B. Kissela, P. Khatri, B. Stettler, O. Adeoye, C. J. Moomaw, et al. Warfarin use leads to larger intracerebral hematomas Neurology, September 30, 2008; 71(14): 1084 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Fric-Shamji, M. F. Shamji, J. Cole, and B. G. Benoit Modifiable risk factors for intracerebral hemorrhage: Study of anticoagulated patients Can Fam Physician, August 1, 2008; 54(8): 1138 - 1139.e4. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein, P. Amarenco, M. Szarek, A. Callahan III, M. Hennerici, H. Sillesen, J. A. Zivin, K.M.A. Welch, and On behalf of the SPARCL Investigators Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study Neurology, June 10, 2008; 70(24_Part_2): 2364 - 2370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Foerch, M. Sitzer, H. Steinmetz, T. Neumann-Haefelin, and for the Arbeitsgruppe Schlaganfall Hessen Pretreatment With Antiplatelet Agents Is Not Independently Associated With Unfavorable Outcome in Intracerebral Hemorrhage Stroke, August 1, 2006; 37(8): 2165 - 2167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Goldstein, S. H. Thomas, V. Frontiero, A. Joseph, C. Engel, R. Snider, E. E. Smith, S. M. Greenberg, and J. Rosand Timing of Fresh Frozen Plasma Administration and Rapid Correction of Coagulopathy in Warfarin-Related Intracerebral Hemorrhage Stroke, January 1, 2006; 37(1): 151 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Steiner, J. Rosand, and M. Diringer Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy: Current Practices and Unresolved Questions Stroke, January 1, 2006; 37(1): 256 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Toyoda, Y. Okada, K. Minematsu, M. Kamouchi, S. Fujimoto, S. Ibayashi, and T. Inoue Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage Neurology, October 11, 2005; 65(7): 1000 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Hart, S. B. Tonarelli, and L. A. Pearce Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas Stroke, July 1, 2005; 36(7): 1588 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stollberger, J. Finsterer, M. H. Eckman, J. Rosand, K. A. Knudsen, S. M. Greenberg, and D. E. Singer Antithrombotic Therapy After Cerebral Hemorrhages * Response Stroke, November 1, 2003; 34 (11): e217 - e218. [Full Text] [PDF]
|
|
|
|
|
|
M. H. Eckman, J. Rosand, K. A. Knudsen, D. E. Singer, and S. M. Greenberg Can Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis Stroke, July 1, 2003; 34(7): 1710 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Man-Son-Hing and A. Laupacis Balancing the Risks of Stroke and Upper Gastrointestinal Tract Bleeding in Older Patients With Atrial Fibrillation Arch Intern Med, March 11, 2002; 162(5): 541 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Sjoblom, H.-G. Hardemark, A. Lindgren, B. Norrving, M. Fahlen, M. Samuelsson, L. Stigendal, D. Stockelberg, A. Taghavi, L. Wallrup, et al. Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter Study Stroke, November 1, 2001; 32(11): 2567 - 2574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Berwaerts, R. S. Dijkhuizen, O. J. Robb, and J. Webster Prediction of Functional Outcome and In-Hospital Mortality After Admission With Oral Anticoagulant-Related Intracerebral Hemorrhage Stroke, November 1, 2000; 31(11): 2558 - 2562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Phan, M. Koh, R. A. Vierkant, and E. F.M. Wijdicks Hydrocephalus Is a Determinant of Early Mortality in Putaminal Hemorrhage Stroke, September 1, 2000; 31(9): 2157 - 2162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Berwaerts and J. Webster Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhages QJM, August 1, 2000; 93(8): 513 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Man-Son-Hing, G. Nichol, A. Lau, and A. Laupacis Choosing Antithrombotic Therapy for Elderly Patients With Atrial Fibrillation Who Are at Risk for Falls Arch Intern Med, April 12, 1999; 159(7): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J.E. Rinkel, N. E.M. Prins, and A. Algra Outcome of Aneurysmal Subarachnoid Hemorrhage in Patients on Anticoagulant Treatment Stroke, January 1, 1997; 28(1): 6 - 9. [Abstract] [Full Text]
|
|
|
|
|
|
The Stroke Prevention in Atrial Fibrillation Inves Bleeding During Antithrombotic Therapy in Patients With Atrial Fibrillation Arch Intern Med, February 26, 1996; 156(4): 409 - 416. [Abstract] [PDF]
|
|
|
|
|
|
R. G. Hart, B. S. Boop, and D. C. Anderson Oral Anticoagulants and Intracranial Hemorrhage : Facts and Hypotheses Stroke, August 1, 1995; 26(8): 1471 - 1477. [Abstract] [Full Text]
|
|
|
|
 |
|
 D.B. Cines and M. Laposata Case 15-1995- A 70-year-old woman with atrial fibrillation and the rapid onset of hemorrhagic manifestations N. Engl. J. Med., May 18, 1995; 332(20): 1363 - 1370. [Full Text] [PDF]
|
|